Lataa...
Aromatase inhibitors-induced bone loss in early breast cancer
Women with breast cancer have an increased prevalence and incidence of fractures. This increased risk of fracture has become most evident following the use of aromatase inhibitors (AIs) as standard adjuvant therapy. AI-induced bone loss occurs at more than twice the rate of physiologic postmenopausa...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4056949/ https://ncbi.nlm.nih.gov/pubmed/24936287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2012.201 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|